Cite
HARVARD Citation
Tury, S. et al. (2018). The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers. Journal of pathology. 246 (1), pp. 103-114. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tury, S. et al. (2018). The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers. Journal of pathology. 246 (1), pp. 103-114. [Online].